Healthcare Realty Trust Incorporated (NYSE:HR – Get Free Report) Director Thomas N. Bohjalian purchased 7,750 shares of the company’s stock in a transaction that occurred on Friday, November 22nd. The shares were purchased at an average cost of $17.39 per share, for a total transaction of $134,772.50. Following the purchase, the director now directly owns 50,002 shares in the company, valued at $869,534.78. This trade represents a 18.34 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Healthcare Realty Trust Stock Down 2.6 %
HR stock traded down $0.47 during trading on Friday, hitting $17.33. 3,207,129 shares of the company’s stock traded hands, compared to its average volume of 3,485,094. The stock has a market capitalization of $6.14 billion, a price-to-earnings ratio of -11.27 and a beta of 0.91. Healthcare Realty Trust Incorporated has a 52 week low of $12.77 and a 52 week high of $18.90. The stock has a fifty day moving average price of $17.76 and a two-hundred day moving average price of $17.23.
Healthcare Realty Trust Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Tuesday, November 12th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 7.16%. The ex-dividend date of this dividend is Tuesday, November 12th. Healthcare Realty Trust’s dividend payout ratio is presently -78.48%.
Hedge Funds Weigh In On Healthcare Realty Trust
Analysts Set New Price Targets
A number of brokerages have recently issued reports on HR. Wedbush lifted their target price on Healthcare Realty Trust from $15.00 to $18.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Wells Fargo & Company reiterated an “underweight” rating and set a $17.00 target price (up from $16.00) on shares of Healthcare Realty Trust in a research note on Tuesday, October 1st. Finally, Scotiabank upped their price target on shares of Healthcare Realty Trust from $17.00 to $18.00 and gave the company a “sector perform” rating in a report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Healthcare Realty Trust currently has a consensus rating of “Hold” and a consensus price target of $17.17.
Read Our Latest Stock Report on Healthcare Realty Trust
About Healthcare Realty Trust
Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.
Read More
- Five stocks we like better than Healthcare Realty Trust
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Tesla Investors Continue to Profit From the Trump Trade
- Are Penny Stocks a Good Fit for Your Portfolio?
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- How Investors Can Find the Best Cheap Dividend Stocks
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.